Orion | ORNBV

Stock Price
65.90
Daily Change
-1.10 -1.64%
Monthly
-0.15%
Yearly
36.67%
Q3 Forecast
67.59

Peers Price Chg Day Year Date
Almirall 10.96 -0.16 -1.44% 27.89% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Oriola-kd 1.17 0.01 0.51% 26.92% Sep/05
Raisio Oyj 2.54 0.02 0.79% 18.14% Sep/05
Recordati 54.05 -0.25 -0.46% 5.16% Sep/05
UCB 206.90 2.30 1.12% 28.99% Sep/05

Indexes Price Day Year Date
Helsinki 10933 81.72 0.75% 10.57% Sep/05
Helsinki 25 4982 42.39 0.86% 10.54% Sep/05

Orion traded at 65.90 this Friday September 5th, decreasing 1.10 or 1.64 percent since the previous trading session. Looking back, over the last four weeks, Orion lost 0.15 percent. Over the last 12 months, its price rose by 36.67 percent. Looking ahead, we forecast Orion to be priced at 67.59 by the end of this quarter and at 65.80 in one year, according to Trading Economics global macro models projections and analysts expectations.

Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.